Search results
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 2 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive via Yahoo Finance· 6 days agoCerevel Therapeutics, a biotechnology company in the midst of being acquired by AbbVie, on Thursday...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 1 day agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 7 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 6 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
This High-Yield Vanguard ETF Could Turn $400 per Month Into $18,900 in Annual Dividend Income
Motley Fool via Yahoo Finance· 5 days agoJPMorgan Chase: 3.4% Broadcom: 3.4% ExxonMobil: 2.8% Home Depot: 2.3% Procter & Gamble: 2.3% Johnson...
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 5 days agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
AbbVie-bound Cerevel reports phase 3 Parkinson's victory in early win for $8.7B deal
FierceBiotech· 6 days agoThe backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 8 hours agoThe following day, i.e., on Apr 26, AbbVie ABBV is slated to release its first-quarter results...